Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Medrogestone

A synthetic progestin derived from progesterone, described in the early 1960s and in clinical use since at least 1966: it is used in menopausal hormone therapy, often together with an oestrogen, and in some gynaecological disorders such as amenorrhoea. This family brings together the active ingredient.

Did you know?Chemically it is 6,17α-dimethyl-6-dehydroprogesterone: it differs from megestrol acetate only in carrying a simple methyl group at position 17α instead of the acetoxy group.

MedrogestoneGo to the active ingredient →
MedrogestoneActive ingredientMedrogestoneCat. No. P-M027-001CAS 977-79-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.